Cabio Biotech (Wuhan) Market Cap

Cabio Biotech (Wuhan) has a market cap or net worth of 3.26 billion as of March 9, 2026. Its market cap has decreased by -5.16% in one year.

Market Cap

3.26B

Enterprise Value

3.12B

Revenue

574.88M

Ranking

n/a

PE Ratio

20.79

Stock Price

19.78

Market Cap Chart

Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 3.26B, a decrease of -41.17%. That is a compound annual growth rate of -8.18%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	3.25B	-16.41%
Dec 31, 2025	3.88B	21.24%
Dec 31, 2024	3.20B	6.31%
Dec 29, 2023	3.01B	-44.60%
Dec 30, 2022	5.44B	-26.24%
Dec 31, 2021	7.37B	55.15%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Guangdong VTR Bio-Tech	3.31B
Shanghai Hile Bio-Technology	3.17B
Shanghai Model Organisms Center	3.42B
Suzhou Fushilai Pharmaceutical	3.04B
Landfar Bio-medicine	2.98B
Beijing Kawin Technology Share-Holding	3.54B
Yantai Zhenghai Biotechnology	3.57B
Novoprotein Scientific	2.94B

Market Cap Rankings